XR, L., BP, L., CLL, S., GH, L., CG, C., TM, T., . . . BE, F. (2022). BNT162b2 mRNA SARS-CoV-2 vaccination does not cause upregulation of endothelial activation markers or hypercoagulability: A prospective, single-arm, longitudinal study. American journal of hematology, 97(4), E141. https://doi.org/10.1002/ajh.26462
Chicago Style (17th ed.) CitationXR, Lim, et al. "BNT162b2 MRNA SARS-CoV-2 Vaccination Does Not Cause Upregulation of Endothelial Activation Markers or Hypercoagulability: A Prospective, Single-arm, Longitudinal Study." American Journal of Hematology 97, no. 4 (2022): E141. https://doi.org/10.1002/ajh.26462.
MLA (9th ed.) CitationXR, Lim, et al. "BNT162b2 MRNA SARS-CoV-2 Vaccination Does Not Cause Upregulation of Endothelial Activation Markers or Hypercoagulability: A Prospective, Single-arm, Longitudinal Study." American Journal of Hematology, vol. 97, no. 4, 2022, p. E141, https://doi.org/10.1002/ajh.26462.